CH501008A - 1-alkyl-1-beta-piperidinoethyl-1 2 3 4-tetrahydro - Google Patents

1-alkyl-1-beta-piperidinoethyl-1 2 3 4-tetrahydro

Info

Publication number
CH501008A
CH501008A CH760869A CH760869A CH501008A CH 501008 A CH501008 A CH 501008A CH 760869 A CH760869 A CH 760869A CH 760869 A CH760869 A CH 760869A CH 501008 A CH501008 A CH 501008A
Authority
CH
Switzerland
Prior art keywords
radical
formula
lower alkyl
ch3o
alkali metal
Prior art date
Application number
CH760869A
Other languages
German (de)
Inventor
Nat Heerdt Ruth Dr Rer
Nat Schmidt Felix Helmut D Rer
Stach Kurt Ing Dr
Helmut Dr Weber
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DEB83296A external-priority patent/DE1301817B/en
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of CH501008A publication Critical patent/CH501008A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines
    • DTEXTILES; PAPER
    • D05SEWING; EMBROIDERING; TUFTING
    • D05BSEWING
    • D05B85/00Needles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Piperidine derivatives of general formula (I) and acid addition salts thereof. - R = H, halo, or CH3O; Z = lower alkyl. - (I) are antitussives, pref. at daily dosages of 10 to 450 mg. - (I) where R=H, Z=CH3, C2H5, C3H7 and their HCl salts; R=CH3O or Cl, Z=CH3 and their HCl salts; or R=CH3O and Z=C2H5. - The reaction is carried out in the presence of an alkali metal, an alkali metal hydride or an alkali metal amide, pref. in an anhydrous inert organic solvent such as hexane, benzene, xylene, etc.

Description

  

  Verfahren zur Herstellung von neuen antidiabetisch wirksamen Sulfonamiden    Aus der deutschen     Patentschrift   <B>1</B>147 948, den bri  tischen Patentschriften 913 716 und 939 608, sowie den  belgischen Patentschriften 609 270, 622 085 und  622 086 sind substituierte 2-Benzolsulfonamido-pyrimi-    dine mit blutzuckersenkender Wirkung bekannt gewor  den. Es wurde nun gefunden, dass     Benzolsulfonylami-          dopyrimidine    der Formel  
EMI0001.0003     
    worin X einen geraden oder verzweigten Kohlenwasser  stoffrest von 1 bis 4 C-Atomen, A einen gegebenenfalls  substituierten Thiophen- oder Furan-Rest, n die Zahlen  0 bis 2, Rl Wasserstoff, einen niederen Alkyl-oder ge  gebenenfalls kernsubstituierten Alkylrest, z.

   B. einen  Aralkyl- oder Alkoxyalkylrest, einen  Cycloalkyl-,  Aryl-,    Alkoxy-,  Alkylmercapto- oder  Alkoxyalkoxy-Rest  bedeuten, sich durch eine besonders starke und langan  haltende antidiabetische Wirkung auszeichnen.  



  Die neuen Verbindungen werden erfindungsgemäss  erhalten, indem man Benzolsulfonyl-guanidine der For  mel II  mit Substanzen der Formel III  
EMI0001.0004     
        
EMI0001.0005     
    oder deren funktionellen, Derivaten umsetzt.  



  Die als Ausgangsverbindungen benutzten     Benzolsul-          fonylguanidine    II können z. B. durch Zusammen    schmelzen der Benzolsulfonamide mit     Guanidincarbo-          nat    erhalten werden. Die erfindungsgemässe Kondensa  tion mit den ss-Dicarbonylverbindungen III kann z. B.  mittels Alkalialkoholat in Alkohol durchgeführt wer-    den. Die ss-Dicarbonylverbindungen werden hierbei in  freier Form oder als funktionelle Derivate, z. B. Ace  tate, eingesetzt; sie können aber auch im  Eintopfver  fahren  nach Vilsmeier aus Aldehydacetalen, Säure  chlorid und Dialkylformamid hergestellt werden.  



  Das erfindungsgemässe Verfahren wird anhand des  nachstehenden Beispiels näher erläutert.  



  <I>Beispiel</I>  2-{4     [ss-(Furan-2-carbonamido)-äthyl]-          benzolsulfonamino}-5-isobutylpyrimidin     In eine Lösung von 9 g     Dimethylformamid    in 40     ml     getrocknetes     Toluol    leitet man unter Rühren bei 0-5  C      12 g Phosgen ein und tropft anschliessend 11 g Isobu  tylacetalaldehyd-diäthylacetal (Kp.16:74 ) zu. Dann  wird 3 Stunden unter Rühren auf 60  C erhitzt,     an-          schliessend    das Toluol im Vakuum abdestilliert und  nach Zugabe von 10 ccm absolutem Methanol     mit    20  30 %iger Natrium-methylat-Lösung auf pH 8 gebracht.

    Das Gemisch wird unter Rühren in eine siedende Mi  schung aus 3 g Natrium in 60 ml absolutem Methanol  und 20 g     4-(ss-Furan-2-carbonamidoäthyl)-          benzolsulfonyl-guanidin    [Fp. 238 ;  hergestellt aus 4-(ss-Furan     2-carbonamidoäthyl)-benzol-          sulfonamid    durch Zusammenschmelzen mit     Natrium-          carbonat    und Guanidin-nitrat] eingetragen und 8 Stun  den unter Rühren gekocht.

   Schliesslich werden die aus  gefallenen     Salze    abgesaugt, das Filtrat eingeengt und  der Destillationsrückstand in verdünnter     Natriumcarbo-          nat-Lösung    gelöst, filtriert und mit verdünnter Salzsäure  ausgefällt. Das aus Äthanol umkristallisierte       2-{-[ss-Furan-2-carbonamido)-äthyl]-          benzolsulfonamido}-5-isobutylpyrimidin          schmilzt    bei 200-201  C.  



  In analoger Weise     erhält    man:       2-[4-(ss-Thiophen-2-carbonamido-äthyl)-          benzol-sulfonamido]-5-isobutyl-pyrimidin     vom Fp. 208-210  C;  2-[4-(ss-3-Äthoxythiophen-2-carbonamido-äthyl)-    benzolsulfonamido]-5-isobutyl-pyrimidin  vom Fp. 170  C;       2-[4-(ss-3-Methylthophen-2-carbonamido-äthyl)-          benzolsulfonamido]-5-isobutyl-pyrimidin     vom Fp. 150  C;  2-[4-(ss-3,4-Tetramethylenthiophen       2-carbonamido-äthyl)-benzol-          sulfonamido]-5-isobutyl-pyrimidin     vom Fp. 193-194  C;

         2-[4-(ss-Furfuroyl-aminoäthyl)-          benzolsulfonamido]-5-isobutyl-pyrimidin     vom Fp. 201-202  C;  2-[4-(ss-3     Äthoxy-thiophen-2-carbonamido-äthyl)-          benzolsulfonamido]-5-propyl-pyrmidin     vom Fp.158-159  C;       2-[4-(ss-3-Methoxythiophen-2-carbonamido-äthyl)-          benzolsulfonyl-amido]-5-isobutyl-pyrimidin     vom Fp. 180-181' C;  2-[4-(ss-3'-Äthoxythiophen-2       carbonyl-N-methyl-aminoäthyl)-          benzolsulfonamido]-5-isobutyl-pyrimidin     vom Fp. 142  C.



  Process for the preparation of new anti-diabetic sulfonamides From the German patent <B> 1 </B> 147 948, the British patents 913 716 and 939 608, and the Belgian patents 609 270, 622 085 and 622 086 are substituted 2-benzenesulfonamido -pyrimidines with blood sugar lowering effect became known. It has now been found that benzenesulfonylami- dopyrimidines of the formula
EMI0001.0003
    wherein X is a straight or branched hydrocarbon radical of 1 to 4 carbon atoms, A is an optionally substituted thiophene or furan radical, n is 0 to 2, Rl is hydrogen, a lower alkyl or optionally ring-substituted alkyl radical, eg.

   B. mean an aralkyl or alkoxyalkyl radical, a cycloalkyl, aryl, alkoxy, alkylmercapto or alkoxyalkoxy radical, are characterized by a particularly strong and long-lasting antidiabetic effect.



  The new compounds are obtained according to the invention by benzenesulfonyl-guanidines of the formula II with substances of the formula III
EMI0001.0004
        
EMI0001.0005
    or their functional derivatives.



  The Benzolsul- fonylguanidine II used as starting compounds can, for. B. can be obtained by melting the benzenesulfonamides with guanidine carbonate. The inventive condensation with the ss-dicarbonyl compounds III can, for. B. be carried out using alkali alcoholate in alcohol. The ss-dicarbonyl compounds are used in free form or as functional derivatives, e.g. B. Ace tate used; But they can also be produced in the Eintopfver according to Vilsmeier from aldehyde acetals, acid chloride and dialkylformamide.



  The method according to the invention is explained in more detail using the following example.



  <I> Example </I> 2- {4 [ss- (furan-2-carbonamido) -ethyl] -benzenesulfonamino} -5-isobutylpyrimidine is passed into a solution of 9 g of dimethylformamide in 40 ml of dried toluene with stirring at 0 -5 C 12 g of phosgene and then 11 g of isobutyl acetalaldehyde diethylacetal (bp 16:74) are added dropwise. The mixture is then heated to 60 ° C. for 3 hours with stirring, the toluene is then distilled off in vacuo and, after 10 cc of absolute methanol has been added, the pH is brought to 8 with 20% strength sodium methylate solution.

    The mixture is poured into a boiling mixture of 3 g of sodium in 60 ml of absolute methanol and 20 g of 4- (ß-furan-2-carbonamidoethyl) -benzenesulfonyl-guanidine [mp. 238; made from 4- (ss-furan 2-carbonamidoethyl) -benzenesulfonamide by melting it with sodium carbonate and guanidine nitrate] and boiled for 8 hours while stirring.

   Finally, the precipitated salts are filtered off with suction, the filtrate is concentrated and the distillation residue is dissolved in dilute sodium carbonate solution, filtered and precipitated with dilute hydrochloric acid. The 2 - {- [ss-furan-2-carbonamido) ethyl] - benzenesulfonamido} -5-isobutylpyrimidine, recrystallized from ethanol, melts at 200-201 C.



  In an analogous manner the following is obtained: 2- [4- (ss-thiophene-2-carbonamido-ethyl) -benzenesulfonamido] -5-isobutyl-pyrimidine of melting point 208-210 C; 2- [4- (ss-3-ethoxythiophene-2-carbonamido-ethyl) -benzenesulfonamido] -5-isobutyl-pyrimidine of melting point 170 C; 2- [4- (ss-3-Methylthophen-2-carbonamido-ethyl) -benzenesulfonamido] -5-isobutyl-pyrimidine of melting point 150 ° C; 2- [4- (ss-3,4-tetramethylenethiophen 2-carbonamido-ethyl) -benzenesulfonamido] -5-isobutyl-pyrimidine, melting point 193-194 C;

         2- [4- (ss-furfuroyl-aminoethyl) -benzenesulfonamido] -5-isobutyl-pyrimidine, melting point 201-202 C; 2- [4- (ss-3 ethoxy-thiophene-2-carbonamido-ethyl) -benzenesulfonamido] -5-propyl-pyrmidine of melting point 158-159 C; 2- [4- (ss-3-methoxythiophene-2-carbonamido-ethyl) -benzenesulfonyl-amido] -5-isobutyl-pyrimidine of melting point 180-181 ° C; 2- [4- (ss-3'-ethoxythiophene-2 carbonyl-N-methyl-aminoethyl) -benzenesulfonamido] -5-isobutyl-pyrimidine of melting point 142 C.

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von neuen antidiabetisch wirksamen Sulfonamiden der Formel I EMI0002.0030 in welcher X einen geraden oder verzweigten Kohlen wasserstoffrest von 1 bis 4 C-Atomen, A einen gegebe nenfalls substituierten Thiophen- oder Furan-Rest, n die Zahlen 0 bis 2, R1 Wasserstoff, einen niederen Alkyl- oder gegebenenfalls kernsubstituierten Phenyl- niederalkyl-Rest und R2 einen gegebenenfalls substitu ierten Alkylrest, einen Cycloalkyl-, Aryl-, Alkoxy-, Alkylmercapto- oder Alkoxyalkoxy-Rest bedeuten, dadurch gekennzeichnet, PATENT CLAIM Process for the production of new antidiabetic sulfonamides of the formula I. EMI0002.0030 in which X is a straight or branched hydrocarbon radical of 1 to 4 carbon atoms, A is an optionally substituted thiophene or furan radical, n is the numbers 0 to 2, R1 is hydrogen, a lower alkyl or optionally ring-substituted phenyl lower alkyl Radical and R2 denote an optionally substituted alkyl radical, a cycloalkyl, aryl, alkoxy, alkylmercapto or alkoxyalkoxy radical, characterized in that dass man Benzolsulfonyl-gua- nidine der Formel II mit Substanzen der Formel III EMI0002.0033 EMI0002.0034 oder deren funktionellen Derivaten umsetzt. UNTERANSPRÜCHE 1. Verfahren nach Patentanspruch, dadurch ge kennzeichnet, dass R2 einen Aralkylrest bedeutet. 2. Verfahren nach Patentanspruch, dadurch ge kennzeichnet, dass R2 einen Alkoxyalkylrest bedeutet. that one benzenesulfonylguanidines of the formula II with substances of the formula III EMI0002.0033 EMI0002.0034 or converts their functional derivatives. SUBClaims 1. Method according to claim, characterized in that R2 is an aralkyl radical. 2. The method according to claim, characterized in that R2 is an alkoxyalkyl radical. <I>Anmerkung des</I> Eidg. <I>Amtes für geistiges Eigentum:</I> Sollten Teile der Beschreibung mit der im Patentanspruch gegebenen Definition der Erfindung nicht in Einklang stehen, so sei daran erinnert, dass gemäss Art. 51 des Patentgesetzes der Patentanspruch für den sachlichen Geltungsbereich des Patentes massgebend ist. <I> Note from the </I> Federal <I> Office for Intellectual Property: </I> If parts of the description are inconsistent with the definition of the invention given in the claim, it should be remembered that according to Art. 51 of the Patent Act, the claim is decisive for the material scope of the patent.
CH760869A 1965-08-17 1966-08-15 1-alkyl-1-beta-piperidinoethyl-1 2 3 4-tetrahydro CH501008A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEB83296A DE1301817B (en) 1965-08-17 1965-08-17 Process for the preparation of 2-benzenesulfonamidopyrimidines substituted in the 5-position
CH1171666A CH476011A (en) 1965-08-17 1966-08-15 Process for the production of new antidiabetic sulfonamides
CH1895968A CH501088A (en) 1965-08-17 1968-12-19 Threading needle

Publications (1)

Publication Number Publication Date
CH501008A true CH501008A (en) 1970-12-31

Family

ID=27176673

Family Applications (3)

Application Number Title Priority Date Filing Date
CH760869A CH501008A (en) 1965-08-17 1966-08-15 1-alkyl-1-beta-piperidinoethyl-1 2 3 4-tetrahydro
CH760969A CH475274A (en) 1965-08-17 1966-08-15 Process for the production of new antidiabetic sulfonamides
CH761069A CH475275A (en) 1965-08-17 1966-08-15 Process for the production of new antidiabetic sulfonamides

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH760969A CH475274A (en) 1965-08-17 1966-08-15 Process for the production of new antidiabetic sulfonamides
CH761069A CH475275A (en) 1965-08-17 1966-08-15 Process for the production of new antidiabetic sulfonamides

Country Status (1)

Country Link
CH (3) CH501008A (en)

Also Published As

Publication number Publication date
CH475274A (en) 1969-07-15
CH475275A (en) 1969-07-15

Similar Documents

Publication Publication Date Title
AT363096B (en) METHOD FOR PRODUCING NEW PHTHALAZINE DERIVATIVES AND THEIR SALTS
DE2237632C3 (en) H4-Hydro3qr-6-methyl-2-pvrimidinyD-3-methyl-pyrazolin-5-one, a process for its preparation and its use for the preparation of 1- (4-methoxy-6methyl-2-pyrimidinyl) -3-methyl -5-methoxypyrazole
DE1023039B (en) Process for the preparation of 5-piperazino-pyridazon- (6) compounds
DE2740331A1 (en) METHOD FOR PRODUCING BLOOD PRESSURE REDUCERS 2- (4-AROYLPIPERAZIN-1-YL) -4-AMINO-6,7-DIMETHOXYCHINAZOLINE
CH501008A (en) 1-alkyl-1-beta-piperidinoethyl-1 2 3 4-tetrahydro
DE2259222A1 (en) NEW, 1,1-DIOXOTHIAZOLIDIN-4-ONE AND THE METHOD FOR THE PREPARATION
DE2065698C3 (en) Process for the preparation of 2-isopropyl-6-methyl-4 (3H) -pyrimidone
DE1055007B (en) Process for the preparation of 3-aminothiophene-2-carboxylic acid esters and the corresponding free carboxylic acids
DE2264413A1 (en) 2,4-DIAMINO-5- (ACYLOXYMETHYL) PYRIMIDINE
DE2406972C3 (en) Process for the preparation of 5-sulfamoylanthranilic acids
AT258911B (en) Process for the preparation of new piperazine derivatives
DE1445774A1 (en) Process for the preparation of benzenesulfonylureas
DE2166019C3 (en) 2-Substituted 1-phenylcyclohex-3en-1-carboxylic acid esters and their salts and processes for their preparation
DE959551C (en) Process for the preparation of 4-substituted 1-carbobenzoxypiperazines
DE589146C (en) Process for the preparation of C, C-disubstituted barbituric acids
DE701901C (en) Process for the preparation of thioformamide compounds
CH411901A (en) Process for the preparation of heterocyclic compounds
CH444884A (en) Process for the production of new basic 1,3-dioxanes and their salts
AT260930B (en) Process for the preparation of new 1- (2-Cycloalkylidenäthyl) piperidines, as well as their acid addition salts
DE2710714C2 (en)
CH629205A5 (en) Process for the preparation of novel 6-substituted tropinones
DE1470291A1 (en) Process for the preparation of thiamine derivatives of the O, S-disubstituted thiol type
CH473812A (en) Process for the production of new antidiabetic sulfonamides
DE1620395A1 (en) Process for the preparation of cycloheptimidazolinium halides
DE1033663B (en) Process for the preparation of N-alkyl-piperidylmethyl-phenthiazines

Legal Events

Date Code Title Description
PL Patent ceased